A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]	Advanced Solid Tumour	Recruiting	Phase 2	2026-08-27		NCT06783647

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Nanjing Leads Biolabs Co.,Ltd	13
Sun Yat-Sen University Cancer Center	74

24 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Guilin Medical University	Guilin	China	4
Anhui Provincial Cancer Hospital	Hefei	China	22
Beijing Cancer Hospital	Beijing	China	208
Beijing Chest Hospital，Capital Medical University	Beijing	China	2
First Hospital of Shanxi Medical University	Taiyuan	China	1
Fujian Cancer Hospital	Fuzhou	China	109
Ganzhou People's Hospital	Ganzhou	China	1
Guangxi Medical University Cancer Hospital	Nanning	China	24
Harbin Medical University Cancer Hospital	Harbin	China	102
Henan Cancer Hospital	Zhengzhou	China	57
Jiangxi Cancer Hospital	Nanchang	China	48
Liaoning Cancer Hospital and Institute	Shenyang	China	1
Mianyang Central Hospital	Mianyang	China	11
Shandong Cancer Hospital	Jinan	China	86
Sichuan Provincial People's Hospital	Chengdu	China	50
Sun Yat-sen University Cancer Center	Guangzhou	China	315
Taizhou Hospital of Zhejiang Province	Taizhou	China	19
The First Affiliated Hospital of Guangdong Pharmaceutical University	Guangzhou	China	1
The First Affiliated Hospital of Henan University of Science & Technology	Luoyang	China	4
The First Affiliated Hospital of Xiamen University	Xiamen	China	2
The Second Xiangya Hospital of Central South University	Changsha	China	67
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	77
Xiangyang Central Hospital	Xiangyang	China	6
Zhejiang Cancer Hospital	Hangzhou	China	164

Clinical trials